Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Infectious Diseases|August 1, 1994
Human immunodeficiency virus type 1 seroconversion in women with genital ulcersP J Plourde, J Pepin, E Agoki, et al.
Harm Reduction Journal|May 13, 2017
Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugsL M Boucher, Z Marshall, A Martin, et al.
Journal of Viral Hepatitis|January 29, 2017
Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort studyN Z Janjua, N Islam, J Wong, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2015
Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitroEdward M Tyndall, Alistair G Draffan, Barbara Frey, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|March 6, 2021
Descriptive exploration of overdose codes in hospital and emergency department discharge data to inform development of drug overdose morbidity surveillance indicator definitions in ICD-10-CMLeigh M Tyndall Snow, Katelyn E Hall, Cody Custis, et al.
HIV Medicine|May 30, 2012
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortalityM B Klein, K C Rollet, S Saeed, et al.
Neuroscience|July 6, 2007
A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body diseaseH L Melrose, C B Kent, J P Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2014
Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agentsAlistair G Draffan, Barbara Frey, Benjamin H Fraser, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV AgentsAlistair G Draffan, Barbara Frey, Brett Pool, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2013
Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitorsLorraine C Axford, Piyush K Agarwal, Kelly H Anderson, et al.
Pageof 3